Publications

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.

Antimycobacterial Susceptibility Testing Group,;

2022

European Respiratory Journal, (2022).59 4 10.1183/13993003.00166-2022.

Estimating the contribution of subclinical tuberculosis disease to transmission – an individual patient data analysis from prevalence surveys.

EMERY, J; Dodd, P; Banu, S; Frascella, B; Garden, F; HORTON, K; Hossain, S; Law, I; Van Leth, F; Marks, G; Nguyen, HB; Nguyen, HV; Onozaki, I; Quelapio, MI; RICHARDS, A; Shaikh, N; Tiemersma, E; WHITE, R; Zaman, K; Cobelens, F; HOUBEN, RM G J;

2022

medRxiv (2022). 10.1101/2022.06.09.22276188.

Design and protocol for a cluster randomised trial of enhanced diagnostics for tuberculosis screening among people living with HIV in hospital in Malawi (CASTLE study).

BURKE, RM; Nyirenda, S; Twabi, HH; Nliwasa, M; Joekes, E; Walker, N; Nyirenda, R; Gupta-Wright, A; FIELDING, K; MacPherson, P; CORBETT, EL;

2022

PloS one, (2022).17 1 10.1371/journal.pone.0261877.

Re-evaluating pathways through the spectrum of tuberculosis disease following M. tuberculosis infection.

HORTON, K; RICHARDS, AS; Emery, JC; Esmail, H; HOUBEN, RM G J;

2022

(2022).

The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: A genotypic analysis.

Walker, TM; Miotto, P; Köser, CU; Fowler, PW; Knaggs, J; Iqbal, Z; Hunt, M; Chindelevitch, L; Farhat, M; Cirillo, DM; Comas, I; Posey, J; Omar, SV; Peto, TE; Suresh, A; Uplekar, S; Laurent, S; Colman, RE; Nathanson, C-M; Zignol, M; Walker, AS; CRyPTIC Consortium,; Seq&amp;Treat Consortium,; Crook, DW; Ismail, N; ... Rodwell, TC.

2022

The Lancet Microbe, (2022).3 4 10.1016/S2666-5247(21)00301-3.

Correction to: Prevalence of Mycobacterium tuberculosis in Sputum and Reported Symptoms Among Clinic Attendees Compared With a Community Survey in Rural South Africa.

GOVENDER, I; Karat, AS; Olivier, S; BAISLEY, K; Beckwith, P; Dayi, N; Dreyer, J; Gareta, D; Gunda, R; Kielmann, K; Koole, O; Mhlongo, N; Modise, T; Moodley, S; Mpofana, X; Ndung'u, T; Pillay, D; Siedner, MJ; Smit, T; Surujdeen, A; Wong, EB; GRANT, AD;

2022

CLINICAL INFECTIOUS DISEASES, (2022).75 2 10.1093/cid/ciac244.

Early risk assessment in paediatric and adult household contacts of confirmed tuberculosis cases by novel diagnostic tests (ERASE-TB): protocol for a prospective, non-interventional, longitudinal, multicountry cohort study.

Marambire, ET; Banze, D; Mfinanga, A; Mutsvangwa, J; Mbunda, TD; Ntinginya, NE; Celso, K; Kallenius, G; CALDERWOOD, CJ; Geldmacher, C; Held, K; Appalarowthu, T; Rieß, F; Panzner, U; Heinrich, N; KRANZER, K; ERASE-TB Consortium,;

2022

BMJ Open, (2022).12 7 10.1136/bmjopen-2022-060985.

End-point definition and trial design to advance tuberculosis vaccine development.

Garcia-Basteiro, AL; WHITE, RG; Tait, D; Schmidt, AC; Rangaka, MX; Quaife, M; Nemes, E; Mogg, R; Hill, PC; Harris, RC; Hanekom, WA; Frick, M; Fiore-Gartland, A; Evans, T; Dagnew, AF; Churchyard, G; Cobelens, F; Behr, MA; Hatherill, M;

2022

European respiratory review, (2022).31 164 10.1183/16000617.0044-2022.

Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion. S1 Data.

Rodriguez, CA; Lodi, S; Horsburgh, CR; Bastard, M; Hewison, C; Huerga, H; Khan, M; KHAN, PY; Khan, U; Oyewusi, L; Padayachee, S; Mitnick, CD; Franke, MF;

2022

, PLOS ONE (2022).

Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients.

Mbandi, SK; PAINTER, H; Penn-Nicholson, A; Toefy, A; Erasmus, M; Hanekom, WA; Scriba, TJ; Lai, RP J; Marais, S; Fletcher, HA; Meintjes, G; Wilkinson, RJ; Cotton, MF; Pahwa, S; Cameron, MJ; Nemes, E;

2022

European Journal of Immunology, (2022).52 7 10.1002/eji.202249815.